Nigeria

in page functions
[French]
 
Total population (2015) 183,523,432
Birth cohort (2015) 7,441,169
Surviving Infants (surviving to 1 year per year, 2015) 6,917,430
Infant mortality rate (deaths < 1 year per 1000 births, 2013) 74/1000
Child mortality rate (deaths < 5 years per 1000 births, 2013) 117/1000
World Bank Index, IDA (2012) 3.44
Gross Nation Income (per capita US$, 2013) 2,710
Co-financing status (2015) Graduating
No. of districts/territories (2013) 774

Gavi support for Nigeria

Type of support

Approvals

2001-2020 (US$)
(31 May 2015)

Commitments

2001-2020 (US$)
(31 May 2015)

Disbursements

2000-2015 (US$)
(31 May 2015)

% Disbursed

(31 May 2015)
2001 2002 2003 2004 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Health system strengthening (HSS 1) $44,704,000 $44,704,000 $42,438,758 95%
Immunisation services support (ISS) $47,324,000 $47,324,000 $47,324,000 100%
Injection safety support (INS) $12,630,270 $12,630,270 $12,610,218 100%
IPV (NVS) $14,022,889 $26,897,889 $13,802,719 98%
Measles SIA (NVS) $10,402,870 $10,402,870 $10,402,870 100%
Measles SIA - Operational costs (OPC) $19,290,000 $19,290,000 $19,290,000 100%
Meningitis A - campaign (NVS) $56,878,516 $56,878,516 $56,057,711 99%
Meningitis A - operational costs (OPC) $43,505,648 $43,505,648 $43,505,648 100%
Penta (NVS) $102,012,982 $102,012,982 $86,529,877 85%
Pneumo (NVS) $48,295,000 $48,295,000 $22,961,001 48%
Vaccine Introduction Grant (VIG) $15,861,921 $15,861,921 $12,161,300 77%
Yellow Fever (NVS) $39,012,946 $39,012,946 $40,348,159 103%
Yellow Fever - campaign (NVS) $11,117,819 $34,689,319 $10,772,883 97%
YF - Operational costs (OPC) $6,495,000 $19,017,000 $6,495,000 100%
Total $471,553,861 $520,522,361 $424,700,143

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nigeria DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2013)

Grade of confidence


N/A
DTP3 - Official country estimates (2013) 65%
M:F sex ratio at birth (2015) 1.06
Household survey: DTP3 coverage for male (2013) 39.40%
Household survey: DTP3 coverage for female (2013) 37.00%
Household survey: Last DTP3 survey (2013) 38%
% districts achieving > 80% DTP3 coverage (2013) 72%
% districts achieving < 50% DTP3 coverage (2013) 5%
MCV WHO/UNICEF estimates (2013) 59%
Polio WHO/UNICEF estimates (2013) 67%

Breakdown of support

Non-vaccine support Vaccine support
43% 57%
$183,824,922 $240,875,216

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nigeria

17 July 2015

India pentavalent scale-up 2014

New coverage figures show more children than ever being reached with immunisation in poorest countries

Coverage trends heading in right direction but major differences remain between countries.

26 June 2015

Cote d Ivoire - IPV launch

Enhanced polio protection to reach 650,000 Côte d’Ivoire children every year

Côte d’Ivoire is introducing the inactivated polio vaccine (IPV) into its routine immunisation programme.

28 April 2015

DRC Polio

More than two million Congolese children per year to be protected against polio

Democratic Republic of Congo to introduce Inactivated Polio Vaccine with Gavi and partners’ support.

close icon

modal window here